Probiotics that modify disease risk

Journal of Nutrition

Volumn 135, Issue 5, 2005, Pages 1294-1298

  Salminen, Seppo J ^a   Gueimonde, Miguel ^a   Isolauri, Erika ^b  

^a Dept of Biochem and Food Chemistry ^*  (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Health effects; Intestinal microbiota; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC DISEASE; ATOPY; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; CONFERENCE PAPER; DIARRHEA; HUMAN; INFLAMMATORY DISEASE; INTESTINE FLORA; INTESTINE MUCOSA; METABOLIC ACTIVATION; RISK REDUCTION;

BACTERIA (MICROORGANISMS); MICROBIOTA;

EID: 18344387591     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.5.1294     Document Type: Conference Paper

References (51)

1. Salminen, S., Bouley, M. C., Boutron-Rualt, M. C., Cummings, J., Franck, A., Gibson, G., Isolauri, E., Moreau, M-C., Roberfroid, M. & Rowland, I. (1998) Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80 (suppl. 1): 147-171.
2. Isolauri, E., Rautava, S., Kalliomaki, M., Kirjavainen, P. & Salminen, S. (2002) Role of probiotics in food hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2: 263-271.
3. Mackie, R. I., Sghir, A. & Gaskins, H. R. (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69: 1035-1045.
4. Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C. & Koga, Y. (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159: 1739-1745.
5. Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K. & Meyer zum Buschenfelde, K. (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102: 448-455.
6. Suau, A., Bonnet, R., Sutren, M., Godon, J-J., Gibson, G., Collins, M. A. & Dore, J. (1999) Direct analysis of genes encoding 16S RNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65: 4799-4807.
7. Vaughan, E., de Vries, M., Zoetendal, E., Ben-Amor, K., Akkermans, A. & de Vos, W. (2002) The intestinal LABs. Antonie Van Leeuwenhoek 82: 341-352.
8. Favier, C., Vaughan, E., de Vos, W. & Akkermans, A. (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 68: 219-226.
9. Benno, Y. & Mitsuoka, T. (1986) Development of intestinal microflora in humans and animals. Bifidobacteria Microflora 5: 13-25.
10. Matsuki, T., Watanabe, K., Tanaka, R., Fukuda, M. & Oyaizu, H. (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl. Environ. Microbiol. 65: 4506-4512.
11. Satokari, R. M., Vaughan, E. E., Akkermans, A. D., Saarela, M. & de Vos, W. M. (2001) Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67: 504-513.
12. Mitsuoka, T. (1982) Recent trends in research on intestinal flora. Bifidobacteria Microflora 1: 3-24.
13. Kalliomaki, M., Kirjavainen, P., Eerola, E., Kero, P., Salminen, S. & Isolauri, E. (2001) Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. J. Allergy Clin. Immunol. 107: 129-134.
14. Björkstén, B., Sepp, E., Julge, K., Voor, T. & Mikelsaar, M. (2001) Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108: 516-520.
15. He, F., Morita, H., Hashimoto, H., Hosoda, M., Kurisaki, J., Ouwenhand, A., Isolauri, E., Benno, Y. & Salminen, S. (2002) Intestinal bifidobacterium species induce varying cytokine production. J. Allergy Clin. Immunol. 109: 1035-1036.
16. Juntunen, M. (2001) Treatment and Prevention of Childhood Diarrhoea with Probiotics and Early Refeeding. Doctoral thesis, University of Turku, Turku, Finland.
17. Lee, Y. K. & Puong, K. Y. (2002) Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate. Br. J. Nutr. 88 (suppl. 1): S101-S108.
18. Dai, D. & Walker, W. A. (1999) Protective nutrients and bacterial colonization in the immature human gut. Adv. Pedriatr. 46: 353-382.
19. Miettinen, M., Lehtonen, A., Julkunen, I. & Matikainen, S. (2000) Lactobacilli and streptococci activate NF-kappa B and STAT signalling pathways in human macrophages. J. Immunol. 164: 3733-3740.
20. Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E. & Salminen, S. (2000) Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30: 1604-1610.
21. Neish, A. S., Gewirtz, A. T. & Zeng, H. (2000) Prokaryotic regulation of epithella responses by inhibition of IkappaB-alpha ubiquitination. Science 289: 1560-1563.
22. Schiffrin, E. J., Brassart, D., Servin, A. L., Rochat, F. & Donnet-Hughes, A. (1997) Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection, Am. J. Clin. Nutr. 66: 515S-520S.
23. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. & Isolauri, E. (2001) Probiotics in the prevention of atopic diseases: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
24. Kirjavainen, P. V., Arvola, T., Salminen, S. J. & Isolauri, E. (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51: 51-55.
25. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
26. Cario, E., Rosenberg, I. M. & Brandwein, S. L. (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164: 966-972.
27. Christensen, H. R., Frøkiaer, H. & Pestka, J. J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168: 171-178.
28. Ouwehand, A., Isolauri, E., He, F., Hashimoto, H., Benno, Y. & Salminen, S. (2001) Differences in bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol. 108: 144-145.
29. Havenaar, R. & Huis in't Veld, J.H.J. (1992) Selection of strains for probiotic use. In: Probiotics, the Scientific Basis (Fuller, R., ed.), pp. 209-224. Chapman and Hall, London, UK.
30. Alander, M., Satokari, R., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T. & von Wright, A. (1999) Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65: 351-354.
31. Ouwehand, A. C., Tolkko, S. & Salminen, S. (2001) The effect of digestive enzymes on the adhesion of probiotic bacteria in vitro. J. Food Sci. 66: 856-859.
32. Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P. & Koivula, T. (1991) A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97.
33. Guandalini, S., Pensabene, L., Zikri, M., Dias, J., Casali, L., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., et al. (2000) Lactobacillus GG administered in an oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30: 54-60.
34. Saavedra, J., Bauman, N., Oung, I., Perman, J. & Yolken, R. (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 47: 709-710.
35. Schell, M. A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., Zwahlen, M-C., Desiere, F., Bork, P., et al. (2002) The genome sequence of Bifidobacteium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. U.S.A. 99: 14422-14427.
36. Ouwehand, A. C., Salminen, S., Tölkkö, S., Roberts, P., Ovaska, J. & Salminen, E. (2002) Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin. Diagn. Lab. Immunol. 9: 184-186.
37. Lee, Y. K., Lim, C. Y., Teng, W. L., Ouwehand, A. C., Tuomola, E. & Salminen, S. (2000) Qualitative approach in the study of adhesion of lactic acid bacteria on intestinal cells and their competition with enterobacteria. Appl. Environ. Microbiol. 66: 3692-3697.
38. Ouwehand, A. C., Tuomola, E. M., Lee, Y. K. & Salminen, S. (2001) Microbial interactions to intestinal mucosal models. Methods Enzymol. 337: 200-212.
39. Pessi, T., Sütas, Y., Hurme, M. & Isolauri, E. (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 12: 1804-1808.
40. Zoetendal, E., Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. & de Vos, W. (2002) Mucosa associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from the faeces. Appl. Environ. Microbiol. 68: 3401-3407.
41. Majamaa, H., Isolauri, E., Saxelin, M. & Vesikari, T. (1995) Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 20: 333-338.
42. Rautava, S., Ruuskanen, O., Ouwehand, A., Salminen, S. & Isolauri E. (2004) The hygiene hypothesis of atopic disease - an extended version. J. Pediatr. Gastroenterol. Nutr. 38: 378-388.
43. Björksten, B., Naaber, P., Sepp, E. & Mikelsaar, M. (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29: 342-346.
44. Kirjavainen, P. V., Apostolou, E., Arvola, T., Salminen, S. J., Gibson, G. R. & Isolauri, E. (2001) Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol. Med. Microbiol. 32: 1-7.
45. Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H. & Isolauri, E. (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controled trial. Lancet 361: 1869-1871.
46. Helin, T., Haahtela, S. & Haahtela, T. (2002) No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controled double-blind study. Allergy 57: 243-246.
47. Hattori, K., Yamamoto, A., Sasai, M., Taniuchi, S., Kojima, T., Kobayashi, Y., Iwamoto, H., Namba, K. & Yaeshima, T. (2003) Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 52: 20-30.
48. Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H. & Salminen, S. (2001) Probiotics: effects on immunity. Am. J. Clin. Nutr. 73: S444-S450.
49. Malin, M., Suomalainen, H., Saxelin, M. & Isolouri, E. (1996) Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Metab. 40: 137-145.
50. Gupta, P., Andrew, H., Kirschner, B. S. & Guandalini, S. (2000) Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr. 31: 453-457.
51. Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D. & Axon, A. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635-639.